Marshall Wace North America’s Kalaris Therapeutics, Inc. Common Stock KLRS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2021 Q3	$8.14M	Hold	14,116	–	–	0.03%	396
2021 Q2	$6.41M	Sell	14,116 -146	-1%	-$66.3K	0.03%	478
2021 Q1	$7.68M	Buy	14,262 +146	+1%	+$78.6K	0.03%	455
2020 Q4	$12.5M	Sell	14,116 -11,140	-44%	-$9.85M	0.06%	333
2020 Q3	$16M	Buy	+25,256	New	+$16M	0.1%	215